NCI-Molecular Analysis for Therapy Choice
1 / 1

NCI-Molecular Analysis for Therapy Choice

Author : olivia-moreira | Published Date : 2025-05-29

Description: NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) Interim Analysis Results Study Chairs: Keith T. Flaherty1, Alice P. Chen2, Peter J. ODwyer3, Barbara A. Conley2, Stanley R. Hamilton4, Mickey Williams5, Robert J. Gray6, Shuli

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Transcript:
Loading transcript�

Download Document

Here is the link to download the presentation.
"NCI-Molecular Analysis for Therapy Choice"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Presentations

FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
NCI Experimental Therapeutics Clinical Trials Network
NCI Experimental Therapeutics Clinical Trials Network
Using Research to Inform Policy and Practice
Using Research to Inform Policy and Practice
NCI in 2017 What’s new in 2017?
NCI in 2017 What’s new in 2017?
Center for Biomedical Informatics and Information Technology (CBIIT)
Center for Biomedical Informatics and Information Technology (CBIIT)
The Global Molecular Diagnostics Market- Industry Trends & Forecast Report 2027
The Global Molecular Diagnostics Market- Industry Trends & Forecast Report 2027
Thank you for joining! Slides and a recording of this webinar will be made availab...
Thank you for joining! Slides and a recording of this webinar will be made availab...
Common Terminology Criteria for Adverse Events (CTCAE) v.4:
Common Terminology Criteria for Adverse Events (CTCAE) v.4:
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
hpcdmeweb.nci.nih.gov NCI Data Management
hpcdmeweb.nci.nih.gov NCI Data Management
How Do Services for People with Intellectual and Developmental Disabilities Compar...
How Do Services for People with Intellectual and Developmental Disabilities Compar...
Individuals With ID/DD Who Communicate Nonverbally
Individuals With ID/DD Who Communicate Nonverbally